Repeat Fine Needle Aspiration Cytology (FNAC) in Thyroid Does Not Help in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS)-Reference-Cited by-同舟云学术

Repeat Fine Needle Aspiration Cytology (FNAC) in Thyroid Does Not Help in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS)

Published:2022-07-23 Issue: Volume: Page:
ISSN:0972-2068
Container-title:Indian Journal of Surgery
language:en
Short-container-title:Indian J Surg

Author:

Ucak Ramazan^ORCID,Turkyilmaz Deniz^ORCID,Aygün Nurcihan^ORCID,Kaya Cemal^ORCID,Ozguven Banu Yilmaz^ORCID,Kabukcuoglu Fevziye^ORCID,Uludag Mehmet^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s12262-022-03515-z.pdf

Reference21 articles.

1. Evranos Ogmen B, Aydin C, Kilinc I et al (2020) Can repeat biopsies change the prognoses of AUS/FLUS nodule? Eur Thyroid J 9:92–98. https://doi.org/10.1159/000504705

2. Allen L, Al Afif A, Rigby MH et al (2019) The role of repeat fine needle aspiration in managing indeterminate thyroid nodules. J Otolaryngol Head Neck Surg 48(1):16. https://doi.org/10.1186/s40463-019-0338-7

3. Jan IS, Lee YT, Wang CM et al (2019) The surgery and repeat aspiration outcomes of the atypia of undetermined significance/follicular lesion of undetermined significance category in The Bethesda System for Reporting Thyroid Cytopathology. Asian J Surg 42(1):144–147. https://doi.org/10.1016/j.asjsur.2018.02.008

4. Cibas ES, Ali SZ (2009) NCI thyroid FNA state of the science conference The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132(5):658–65. https://doi.org/10.1309/AJCPPHLWMI3JV4LA

5. Cibas ES, Ali SZ (2017) The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 27(11):1341–1346. https://doi.org/10.1089/thy.2017.0500

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic models for predicting malignancy in thyroid nodules classified as Bethesda Category III in an endemic region;Diagnostic Cytopathology;2024-01-25